Mortality, sepsis, and organ failure in hospitalized patients with cirrhosis vary by type of infection

被引:14
作者
Atteberry, Preston [1 ]
Biederman, Benjamin [1 ]
Jesudian, Arun [2 ]
Lucero, Catherine [2 ]
Brown, Robert S., Jr. [2 ]
Verna, Elizabeth [3 ]
Sundaram, Vinay [4 ]
Fortune, Brett [2 ]
Rosenblatt, Russell [2 ]
机构
[1] Columbia Univ, NewYork Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[2] Columbia Univ, New York Presbyterian Hosp, Weill Cornell Med Ctr, Div Gastroenterol & Hepatol,Weill Cornell Med, New York, NY USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, Ctr Liver Dis & Transplantat, New York, NY USA
[4] Cedars Sinai Med Ctr, Dept Med, Div Digest & Liver Dis, Los Angeles, CA USA
关键词
acute-on-chronic liver failure; decompensated cirrhosis; Nationwide Readmissions Database; pneumonia; CLOSTRIDIUM-DIFFICILE INFECTION; CHRONIC LIVER-FAILURE; PREVALENCE; TRENDS;
D O I
10.1111/jgh.15633
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Infection is associated with substantial morbidity and mortality in cirrhosis, but presumably, not all infections carry the same risk of mortality. We compared outcomes of different sites of infection in a nationally representative sample of inpatients with cirrhosis. Methods We queried the Nationwide Readmissions Database for patients with cirrhosis from 2011 to 2014. Cirrhosis and infection diagnoses were identified by previously used algorithms of ICD-9 codes. The following infections were compared: urinary tract infection (UTI), pneumonia, cellulitis, spontaneous bacterial peritonitis (SBP), and Clostridium difficile infection (CDI). The primary outcome was inpatient mortality. Secondary outcomes included sepsis, any organ failure, multiple organ failures, and 30-day readmission. Outcomes were analyzed using logistic regression and included a priori covariates. Results A total of 1 798 830 weighted index admissions were identified. Infection was present in 29.2% overall-including UTI (13.7%), pneumonia (8.9%), cellulitis (5.2%), CDI (2.8%), and SBP (2.0%). Mortality was significantly higher in pneumonia (19.6%), SBP (18.6%), and CDI (17.4%) compared with cellulitis (7.6%) and UTI (11.8%). Sepsis, any, and multiple organ failures were most commonly seen in pneumonia, SBP, and CDI. Multivariable analysis demonstrated that pneumonia had the highest associated mortality (odds ratio [OR] 2.73, confidence interval [CI] 2.68-2.80) and multiple organ failures (OR 3.59, CI 3.50-3.68). Significantly increased 30-day readmission was seen only with SBP (24.9%). Conclusions Outcomes of inpatients with cirrhosis vary significantly depending on the type of infection. The severity and epidemiology of infection in cirrhosis appears to be shifting with pneumonia, not SBP, having the highest prevalence of multiple organ failures and inpatient mortality.
引用
收藏
页码:3363 / 3370
页数:8
相关论文
共 33 条
  • [1] Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
    Arvaniti, Vasiliki
    D'Amico, Gennaro
    Fede, Giuseppe
    Manousou, Pinelopi
    Tsochatzis, Emmanuel
    Pleguezuelo, Maria
    Burroughs, Andrew Kenneth
    [J]. GASTROENTEROLOGY, 2010, 139 (04) : 1246 - +
  • [2] Bajaj Jasmohan S, 2019, Clin Liver Dis (Hoboken), V14, P107, DOI 10.1002/cld.827
  • [3] Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures
    Bajaj, Jasmohan S.
    O'Leary, Jacqueline G.
    Reddy, K. Rajender
    Wong, Florence
    Biggins, Scott W.
    Patton, Heather
    Fallon, Michael B.
    Garcia-Tsao, Guadalupe
    Maliakkal, Benedict
    Malik, Raza
    Subramanian, Ram M.
    Thacker, Leroy R.
    Kamath, Patrick S.
    [J]. HEPATOLOGY, 2014, 60 (01) : 250 - 256
  • [4] Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience
    Bajaj, Jasmohan S.
    O'Leary, Jacqueline G.
    Reddy, K. Rajender
    Wong, Florence
    Olson, Jody C.
    Subramanian, Ram M.
    Brown, Geri
    Noble, Nicole A.
    Thacker, Leroy R.
    Kamath, Patrick S.
    [J]. HEPATOLOGY, 2012, 56 (06) : 2328 - 2335
  • [5] Immune Dysfunction and Infections in Patients With Cirrhosis
    Bonnel, Alexander R.
    Bunchorntavakul, Chalermrat
    Reddy, K. Rajender
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (09) : 727 - 738
  • [6] Bacterial infections in cirrhosis: A critical review and practical guidance
    Bunchorntavakul, Chalermrat
    Chamroonkul, Naichaya
    Chavalitdhamrong, Disaya
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 307 - 321
  • [7] Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes
    Cullaro, Giuseppe
    Sharma, Rajani
    Trebicka, Jonel
    Cardenas, Andres
    Verna, Elizabeth C.
    [J]. LIVER TRANSPLANTATION, 2020, 26 (02) : 283 - 293
  • [8] Comorbidity measures for use with administrative data
    Elixhauser, A
    Steiner, C
    Harris, DR
    Coffey, RN
    [J]. MEDICAL CARE, 1998, 36 (01) : 8 - 27
  • [9] Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
    Fernandez, Javier
    Prado, Veronica
    Trebicka, Jonel
    Amoros, Alex
    Gustot, Thierry
    Wiest, Reiner
    Deulofeu, Carme
    Garcia, Elisabet
    Acevedo, Juan
    Fuhrmann, Valentin
    Durand, Francois
    Sanchez, Cristina
    Papp, Maria
    Caraceni, Paolo
    Vargas, Victor
    Banares, Rafael
    Piano, Salvatore
    Janicko, Martin
    Albillos, Agustin
    Alessandria, Carlo
    Soriano, German
    Welzel, Tania M.
    Laleman, Wim
    Gerbes, Alexander
    De Gottardi, Andrea
    Merli, Manuela
    Coenraad, Minneke
    Saliba, Faouzi
    Pavesi, Marco
    Jalan, Rajiv
    Gines, Pere
    Angeli, Paolo
    Arroyo, Vicente
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 398 - 411
  • [10] Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis
    Fernandez, Javier
    Acevedo, Juan
    Prado, Veronica
    Mercado, Mario
    Castro, Miriam
    Pavesi, Marco
    Arteaga, Mireya
    Sastre, Lydia
    Juanola, Adria
    Gines, Pere
    Arroyo, Vicente
    [J]. LIVER INTERNATIONAL, 2017, 37 (03) : 385 - 395